Literature DB >> 19870726

IMMUNOLOGICAL STUDIES OF A HEAT-STABLE SUBSTANCE ISOLATED FROM TISSUES INFECTED WITH VACCINE VIRUS.

R F Parker1.   

Abstract

We have shown that it is possible to obtain from extracts of vaccine virus-infected tissues a substance or substances, apparently protein, which are serologically active, and which are specifically related to vaccinal infection. The present investigation is concerned with a study of their immunological reactions. Their intraperitoneal injection in rabbits is followed by the appearance in the serum of these animals of antibodies directed specifically against them. The precipitating capacities of this serum are entirely removed after addition of appropriate quantities of heated vaccine virus extract, indicating that antibodies against only the heat-stable antigens have been produced. Further evidence of the specificity of the antibodies is gained from the reverse experiment, that is, absorption of a virus extract with the serum. We have shown that under suitable conditions the serum will remove S antigen specifically leaving the labile substances in solution. This would apparently indicate that they are serologically distinct although both are vaccinal products. Serum of animals injected with the S substance and containing antibodies against it in high titer is apparently capable of neutralizing minute amounts of active virus. The animals providing the serum are, however, without demonstrable resistance to vaccinia. The significance of the neutralizing activity of the serum is debatable because it is of a greatly different order of magnitude from that which follows infection with vaccinia.

Entities:  

Year:  1938        PMID: 19870726      PMCID: PMC2180319          DOI: 10.1084/jem.67.3.361

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  A New Method for the Rapid Staining of Myelin Sheaths.

Authors:  W K Smith; B Quigley
Journal:  Am J Pathol       Date:  1937-05       Impact factor: 4.307

2.  IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : VI. ISOLATION OF A HEAT-STABLE, SEROLOGICALLY ACTIVE SUBSTANCE FROM TISSUES INFECTED WITH VACCINE VIRUS.

Authors:  R F Parker; T M Rivers
Journal:  J Exp Med       Date:  1937-01-31       Impact factor: 14.307

3.  STUDIES ON THE SOLUBLE PRECIPITABLE SUBSTANCES OF VACCINIA : II. THE SOLUBLE PRECIPITABLE SUBSTANCES OF DERMAL VACCINE.

Authors:  J Craigie; F O Wishart
Journal:  J Exp Med       Date:  1936-10-31       Impact factor: 14.307

  3 in total
  7 in total

1.  THE LS-ANTIGEN OF VACCINIA : I. INHIBITION OF L- AND S-ANTIBODIES BY SUBSTANCES IN TREATED VACCINE DERMAL FILTRATE.

Authors:  J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1942-01-31       Impact factor: 14.307

2.  SOME CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA.

Authors:  J E Smadel; G I Lavin; R J Dubos
Journal:  J Exp Med       Date:  1940-02-29       Impact factor: 14.307

3.  THE LS-ANTIGEN OF VACCINIA : IV. CHEMICAL ANALYSIS OF LS AND THE EFFECT OF CHYMOTRYPSIN ON LS.

Authors:  J E Smadel; C L Hoagland; T Shedlovsky
Journal:  J Exp Med       Date:  1943-02-01       Impact factor: 14.307

4.  THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY.

Authors:  T Shedlovsky; J E Smadel
Journal:  J Exp Med       Date:  1942-01-31       Impact factor: 14.307

5.  INFECTIOUS MYXOMATOSIS OF RABBITS : STUDIES OF A SOLUBLE ANTIGEN ASSOCIATED WITH THE DISEASE.

Authors:  T M Rivers; S M Ward; J E Smadel
Journal:  J Exp Med       Date:  1939-01-01       Impact factor: 14.307

6.  IMMUNITY IN MUMPS : VI. EXPERIMENTS ON THE VACCINATION OF HUMAN BEINGS WITH FORMOLIZED MUMPS VIRUS.

Authors:  J Stokes; J F Enders; E P Maris; L W Kane
Journal:  J Exp Med       Date:  1946-10-31       Impact factor: 14.307

7.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : III. IMMUNOLOGICAL PROPERTIES OF THE C-REACTIVE PROTEIN AND ITS DIFFERENTIATION FROM NORMAL BLOOD PROTEINS.

Authors:  C M Macleod; O T Avery
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.